loadpatents
name:-0.044387102127075
name:-0.026208162307739
name:-0.015156984329224
SCARIA; Abraham Patent Filings

SCARIA; Abraham

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCARIA; Abraham.The latest application filed is for "compositions and methods for treating and preventing macular degeneration".

Company Profile
15.24.40
  • SCARIA; Abraham - Framingham MA
  • Scaria; Abraham - Cambridge MA
  • Scaria; Abraham - Bridgewater NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions And Methods For Treating And Preventing Macular Degeneration
App 20220288232 - SCARIA; Abraham
2022-09-15
Use of iNOS inhibitors to increase viral yield in culture
Grant 11,299,715 - Pechan , et al. April 12, 2
2022-04-12
Materials And Methods For Treatment Of Autosomal Dominant Cone-rod Dystrophy
App 20220081680 - Takeuchi; Ryo ;   et al.
2022-03-17
Fusion Proteins Comprising Pdgf And Vegf Binding Portions And Methods Of Using Thereof
App 20220064262 - PECHAN; Peter ;   et al.
2022-03-03
Materials And Methods For Treatment Of Usher Syndrome Type 2a And/or Non-syndromic Autosomal Recessive Retinitis Pigmentosa (arrp)
App 20220049247 - Allocca; Mariacarmela ;   et al.
2022-02-17
Materials And Methods For Treatment Of Usher Syndrome Type 2a
App 20210403905 - KANTARDZHIEVA; Albena ;   et al.
2021-12-30
Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
Grant 11,118,177 - Allocca , et al. September 14, 2
2021-09-14
Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof
Grant 11,084,864 - Pechan , et al. August 10, 2
2021-08-10
Materials and methods for treatment of usher syndrome type 2A
Grant 11,072,792 - Kantardzhieva , et al. July 27, 2
2021-07-27
Aav Vectors For Retinal And Cns Gene Therapy
App 20210189430 - SCARIA; Abraham ;   et al.
2021-06-24
Materials and methods for treatment of autosomal dominant cone-rod dystrophy
Grant 10,995,328 - Takeuchi , et al. May 4, 2
2021-05-04
AAV vectors for retinal and CNS gene therapy
Grant 10,982,228 - Scaria , et al. April 20, 2
2021-04-20
Compositions And Methods For Treating And Preventing Macular Degeneration
App 20210040484 - WADSWORTH; Samuel ;   et al.
2021-02-11
Materials And Methods For Controlling Gene Editing
App 20200407729 - TAKEUCHI; Ryo ;   et al.
2020-12-31
Materials And Methods For Treatment Of Autosomal Dominant Cone-rod Dystrophy
App 20200385696 - TAKEUCHI; Ryo ;   et al.
2020-12-10
Materials And Methods For Treatment Of Usher Syndrome Type 2a
App 20200354717 - KANTARDZHIEVA; Albena ;   et al.
2020-11-12
Fusion proteins and methods for inhibiting IL-17 pathways
Grant 10,822,391 - Scaria , et al. November 3, 2
2020-11-03
Adeno-associated viral vectors for treating myocilin (MYOC) glaucoma
Grant 10,821,193 - Pechan , et al. November 3, 2
2020-11-03
Materials And Methods For Treatment Of Autosomal Dominant Retinitis Pigmentosa
App 20200332288 - KANTARDZHIEVA; Albena ;   et al.
2020-10-22
Materials And Methods For Treatment Of Usher Syndrome Type 2a And/or Non-syndromic Autosomal Recessive Retinitis Pigmentosa (arrp)
App 20200318108 - ALLOCCA; Mariacarmela ;   et al.
2020-10-08
Materials and methods for treatment of autosomal dominant retinitis pigmentosa
Grant 10,662,425 - Kantardzhieva , et al.
2020-05-26
Compositions and methods for treating and preventing macular degeneration
Grant 10,640,771 - Wadsworth , et al.
2020-05-05
Fusion Proteins Comprising Pdgf And Vegf Binding Portions And Methods Of Using Thereof
App 20190345223 - Pechan; Peter ;   et al.
2019-11-14
Materials And Methods For Treatment Of Autosomal Dominant Retinitis Pigmentosa
App 20190153440 - Kantardzhieva; Albena ;   et al.
2019-05-23
Materials And Methods For Treatment Of Autosomal Dominant Retinitis Pigmentosa
App 20190153441 - Kantardzhieva; Albena ;   et al.
2019-05-23
Gene Editing Of Deep Intronic Mutations
App 20190022192 - RUAN; Guoxiang ;   et al.
2019-01-24
Nucleic acids encoding fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof
Grant 10,183,983 - Pechan , et al. Ja
2019-01-22
Multimeric Constructs
App 20180155417 - Scaria; Abraham ;   et al.
2018-06-07
Fusion Proteins Comprising Pdgf And Vegf Binding Portions And Methods Of Using Thereof
App 20170342127 - PECHAN; Peter ;   et al.
2017-11-30
Multimeric constructs
Grant 9,815,892 - Scaria , et al. November 14, 2
2017-11-14
Adeno-associated Viral Vectors For Treating Myocilin (myoc) Glaucoma
App 20170304465 - PECHAN; Peter ;   et al.
2017-10-26
Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof
Grant 9,637,534 - Pechan , et al. May 2, 2
2017-05-02
Aav Vectors For Retinal And Cns Gene Therapy
App 20170096683 - SCARIA; Abraham ;   et al.
2017-04-06
Compositions And Methods For Treating And Preventing Macular Degeneration
App 20170007719 - Scaria; Abraham
2017-01-12
Compositions And Methods For Treating And Preventing Macular Degeneration
App 20160068844 - WADSWORTH; Samuel ;   et al.
2016-03-10
Use Of Inos Inhibitors To Increase Viral Yield In Culture
App 20150353899 - Pechan; Peter ;   et al.
2015-12-10
Fusion Proteins Comprising Pdgf And Vegf Binding Portions And Methods Of Using Thereof
App 20140315804 - PECHAN; Peter ;   et al.
2014-10-23
Multimeric Constructs
App 20140193411 - Scaria; Abraham ;   et al.
2014-07-10
Combination therapies for treating type 1 diabetes
Grant 8,758,761 - Atkinson , et al. June 24, 2
2014-06-24
Multimeric constructs
Grant 8,658,602 - Scaria , et al. February 25, 2
2014-02-25
Multimeric Constructs
App 20110268735 - Scaria; Abraham ;   et al.
2011-11-03
Multimeric constructs
Grant 7,928,072 - Scaria , et al. April 19, 2
2011-04-19
Compositions And Methods For Inhibiting Interleukin Pathways
App 20110052585 - Scaria; Abraham ;   et al.
2011-03-03
Methods For Treating Blood Coagulation Disorders
App 20110034539 - WADSWORTH; Samuel ;   et al.
2011-02-10
Combination Therapies for Treating Type 1 Diabetes
App 20100322894 - Atkinson; Mark A ;   et al.
2010-12-23
Use Of Rapamycin To Inhibit Immune Response And Induce Tolerance To Gene Therapy Vector And Encoded Transgene Products
App 20100196401 - Scaria; Abraham
2010-08-05
Methods for treating blood coagulation disorders
Grant 7,615,537 - Scaria , et al. November 10, 2
2009-11-10
Materials and Methods for Reversing Type-1 Diabetes
App 20090162345 - Atkinson; Mark A. ;   et al.
2009-06-25
Use Of Rapamycin To Inhibit Response And Induce Tolerance To Gene Therapy Vector And Encoded Transgene Products
App 20080096808 - Scaria; Abraham
2008-04-24
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
Grant 7,307,068 - Scaria December 11, 2
2007-12-11
Multimeric constructs
App 20070224178 - Scaria; Abraham ;   et al.
2007-09-27
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
Grant 7,045,508 - Scaria May 16, 2
2006-05-16
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
App 20060094684 - Scaria; Abraham
2006-05-04
Enhanced anti-tumor immunity
Grant 7,014,848 - Kaplan , et al. March 21, 2
2006-03-21
Adenoviral vectors having nucleic acids encoding immunomodulatory molecules
App 20040023389 - Scaria, Abraham ;   et al.
2004-02-05
Methods for treating blood coagulation disorders
App 20030229036 - Scaria, Abraham ;   et al.
2003-12-11
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
App 20020164306 - Scaria, Abraham
2002-11-07
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
App 20020019361 - Scaria, Abraham
2002-02-14
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
App 20020014242 - Scaria, Abraham
2002-02-07
Adenoviral vectors capable of facilitating increased persistence of transgene expression
Grant 6,020,191 - Scaria , et al. February 1, 2
2000-02-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed